GlassScriptPhysician profile
Amberly Winley
NPI 1962752139
$1,285.09
in general payments reported to CMS, 2019-2025
23 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.52 · 2020: $15.16 · 2021: $95.56 · 2022: $141 · 2023: $196 · 2024: $438 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.61 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $258.69 | 2024-2025 | Veozah |
| Abbvie INC. | $150.32 | 2019-2025 | |
| Davol INC. | $131.08 | 2024-2025 | Arista, Arista Ah Flexitip |
| Optumhealth Care Solutions, LLC | $111.87 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Pfizer INC. | $88.00 | 2019-2025 | |
| Organon LLC | $67.99 | 2024-2025 | Nexplanon |
| Lilly USA, LLC | $50.97 | 2024 | Zepbound |
| Coopersurgical, INC. | $47.62 | 2019-2025 | Summit Doppler, Sos |
| Kci USA, INC. | $46.90 | 2022-2023 | Prevena |
| Meditrina | $44.75 | 2022 | |
| Novo Nordisk INC | $43.87 | 2022-2025 | Wegovy |
| Cumberland Pharmaceuticals, INC. | $41.63 | 2023-2024 | Caldolor |
| Bayer Healthcare Pharmaceuticals INC. | $30.02 | 2019-2022 | |
| Biogen, INC. | $28.05 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $19.71 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $17.68 | 2021 | |
| Agile Therapeutics, INC. | $15.76 | 2021 | |
| Smith+Nephew, INC. | $15.73 | 2019 | |
| Hologic Sales and Service, LLC | $15.43 | 2024 | Acessa Provu System |
| Boston Scientific Corporation | $15.16 | 2020 | |
| Millicent US INC | $14.97 | 2024 | Intrarosa |
| Sumitomo Pharma America, INC. | $14.76 | 2025 | Myfembree |
| Merck Sharp & Dohme LLC | $14.13 | 2025 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amberly Winley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.